News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
James Davis: Ide-cel vs cilita-cel in R/R multiple myeloma
James Davis/X
Feb 23, 2025, 10:27

James Davis: Ide-cel vs cilita-cel in R/R multiple myeloma

James Davis, Assistant professor & malignant hematology pharmacist at MUSC Hollings Cancer Center, shared an article by Doris K. Hansen, et al. on X:

“In lieu of a head-to-head trial comparing ide-cel and cilta-cel (which we will never get), check out our study in Journal of Clinical Oncology comparing these products in over 600 patients.

Congrats Doris Hansen, Krina Patel, Surbhi Sidana, Danai Dima, Charlotte B Wagner.”

Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma.

Authors: Doris K. Hansen, et al.

James Davis: Ide-cel vs cilita-cel in R/R multiple myeloma

 

cancer CharlotteBWagner Ciltacabtagene Autoleucel Danai Dima Doris Hansen Doris K. Hansen fight against cancer Global fight against cancer idecabtagene vicleucel James Davis Journal of Clinical Oncology Krina Patel multiple myeloma MUSC Hollings Cancer Center OncoDaily Oncology Surbhi Sidana
Special Coverage
Insight
Sep 9, 2025, 18:18
Debra Patt: The Augmented Oncologist
Positive
Sep 9, 2025, 18:07
Anirban Maitra: Meeting the New Medical Director of our Liver Cancer Program at NYU Langone Health
Voices
Sep 9, 2025, 17:59
Abstract Submission Is Open for ESTRO 2026
Blog Posts
Sep 9, 2025, 17:52
Celebrating All the Extraordinary Pediatric Oncology Nurses Around the World - Childhood Cancer International
Insight
Sep 9, 2025, 17:43
Jeremy Slone: 1995 Study on Pediatric Kaposi Sarcoma in Zambia
Voices
Sep 9, 2025, 17:28
Miguel Bronchud: Lancet Oncology Abstract on Calls to Reform Cancer MDTs in the English NHS
Insight
Sep 9, 2025, 17:15
EORTC Highlights New Research on Immunogenic Effects of Radiotherapy in Cancer Care
Blog Posts
Sep 9, 2025, 17:03
Brian Walusimbi: Grateful for Aladina Foundation's Love and Support in Uganda
Insight
Sep 9, 2025, 16:53
NIH Launches a New Initiative to Create a 21st Century Biosafety Framework
Blog Posts
Sep 9, 2025, 16:51
Thanking Stephen V Liu and the IASLC Staff at WCLC25
Insight
Sep 9, 2025, 16:45
Mulugeta Ayalew Yimer: Urgent Need for Practical Strategies to Reduce Treatment Abandonment for Children with Cancer
Insight
Sep 9, 2025, 15:59
Big News for MSS Colorectal Cancer - Fight Colorectal Cancer